Carbon-rich planet formation in a solar composition disk

The C--to--O ratio is a crucial determinant of the chemical properties of planets. The recent observation of WASP 12b, a giant planet with a C/O value larger than that estimated for its host star, poses a conundrum for understanding the origin of this elemental ratio in any given planetary system. In this paper, we propose a mechanism for enhancing the value of C/O in the disk through the transport and distribution of volatiles. We construct a model that computes the abundances of major C and O bearing volatiles under the influence of gas drag, sublimation, vapor diffusion, condensation and coagulation in a multi--iceline 1+1D protoplanetary disk. We find a gradual depletion in water and carbon monoxide vapors inside the water's iceline with carbon monoxide depleting slower than water. This effect increases the gaseous C/O and decreases the C/H ratio in this region to values similar to those found in WASP 12b's day side atmosphere. Giant planets whose envelopes were accreted inside the water's iceline should then display C/O values larger than those of their parent stars, making them members of the class of so-called ``carbon-rich planets''.Comment: 8 pages, 4 figures, accepted for publication Ap

EFFECTS OF ORALLY ADMINISTERED ENTEROCOCCUS FAECIUM ON THE IMMUNE SYSTEMIC RESPONSE AND INTESTINAL EPITHELIAL STRUCTURE IN BALB/C MICE IMMUNIZED BY BOVINE Î’-LACTOGLOBULIN

Objective: Determine the effect of Enterococcus faecium on systemic immune response and its effect on the intestinal epithelial structure in the Balb/c mice. Methods: Thirty Balb/c mice were dispatched in three lots of 10 mice each. During an initial period of 18 days, the animals from the first lot received via an oral way suspension of 0,3 mL containing 108 ufc/mL of Enterococcus faecium,for the second and the third lot received 0,3 mL of a saline solution. In a second period of time, mice from the first and second lots were immunised via parenteral way using β-Lg. Then they were sacrified on the 50th day after the end of the first period (18 days). The level of IgG anti-β-Lg was determined in the sera by the ELISA, and histologic studies were conducted on the jejunum fragments. Results: Our results show that anti β-Lactoglobulin IgG titers were significantly reduced in immunized mice that received the Enterococcus faecium (1/280th) (***p<0,001). The histological studies of the intestinal epithelium shows long intestinal villi (53,88 ± 1,38µm) with diminished intra-epithelial lymphocytes. Conclusion: The study shows that Enterococcus faecium PC4.1 may help protect the intestinal epithelium integrity by maintaining the structure of the villi and has the ability to decrease the systemic immune response to β-lactoglobulin

Effectiveness of pharmacological treatments for severe agitation in real-world emergency settings: protocol of individual-participant-data network meta-analysis.

BACKGROUND Severe psychomotor agitation and aggression often require immediate pharmacological intervention, but clear evidence-based recommendations for choosing among the multiple options are lacking. To address this gap, we plan a systematic review and individual-participant-data network meta-analysis to investigate their comparative effectiveness in real-world emergency settings with increased precision. METHODS We will include randomized controlled trials investigating intramuscular or intravenous pharmacological interventions, as monotherapy or in combination, in adults with severe psychomotor agitation irrespective of the underlying diagnosis and requiring rapid tranquilization in general or psychiatric emergency settings. We will exclude studies before 2002, those focusing on specific reasons for agitation and placebo-controlled trials to avoid concerns related to the transitivity assumption and potential selection biases. We will search for eligible studies in BIOSIS, CENTRAL, CINAHL Plus, Embase, LILACS, MEDLINE via Ovid, PubMed, ProQuest, PsycINFO, ClinicalTrials.gov, and WHO-ICTRP. Individual-participant data will be requested from the study authors and harmonized into a uniform format, and aggregated data will also be extracted from the studies. At least two independent reviewers will conduct the study selection, data extraction, risk-of-bias assessment using RoB 2, and applicability evaluation using the RITES tool. The primary outcome will be the number of patients achieving adequate sedation within 30 min after treatment, with secondary outcomes including the need for additional interventions and adverse events, using odds ratios as the effect size. If enough individual-participant data will be collected, we will synthesize them in a network meta-regression model within a Bayesian framework, incorporating study- and participant-level characteristics to explore potential sources of heterogeneity. In cases where individual-participant data are unavailable, potential data availability bias will be explored, and models allowing for the inclusion of studies reporting only aggregated data will be considered. We will assess the confidence in the evidence using the Confidence in Network Meta-Analysis (CINeMA) approach. DISCUSSION This individual-participant-data network meta-analysis aims to provide a fine-tuned synthesis of the evidence on the comparative effectiveness of pharmacological interventions for severe psychomotor agitation in real-world emergency settings. The findings from this study can greatly be provided clearer evidence-based guidance on the most effective treatments. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42023402365

A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability

AIM To evaluate a standardised MRI acquisition protocol and a new image rating scale for disease severity in patients with progressive supranuclear palsy (PSP) and multiple systems atrophy (MSA) in a large multicentre study. METHODS The MRI protocol consisted of two-dimensional sagittal and axial T1, axial PD, and axial and coronal T2 weighted acquisitions. The 32 item ordinal scale evaluated abnormalities within the basal ganglia and posterior fossa, blind to diagnosis. Among 760 patients in the study population (PSP = 362, MSA = 398), 627 had per protocol images (PSP = 297, MSA = 330). Intra-rater (n = 60) and inter-rater (n = 555) reliability were assessed through Cohen's statistic, and scale structure through principal component analysis (PCA) (n = 441). Internal consistency and reliability were checked. Discriminant and predictive validity of extracted factors and total scores were tested for disease severity as per clinical diagnosis. RESULTS Intra-rater and inter-rater reliability were acceptable for 25 (78%) of the items scored (≥ 0.41). PCA revealed four meaningful clusters of covarying parameters (factor (F) F1: brainstem and cerebellum; F2: midbrain; F3: putamen; F4: other basal ganglia) with good to excellent internal consistency (Cronbach α 0.75-0.93) and moderate to excellent reliability (intraclass coefficient: F1: 0.92; F2: 0.79; F3: 0.71; F4: 0.49). The total score significantly discriminated for disease severity or diagnosis; factorial scores differentially discriminated for disease severity according to diagnosis (PSP: F1-F2; MSA: F2-F3). The total score was significantly related to survival in PSP (p<0.0007) or MSA (p<0.0005), indicating good predictive validity. CONCLUSIONS The scale is suitable for use in the context of multicentre studies and can reliably and consistently measure MRI abnormalities in PSP and MSA. Clinical Trial Registration Number The study protocol was filed in the open clinical trial registry (http://www.clinicaltrials.gov) with ID No NCT00211224

The SIB Swiss Institute of Bioinformatics' resources: focus on curated databases

The SIB Swiss Institute of Bioinformatics (www.isb-sib.ch) provides world-class bioinformatics databases, software tools, services and training to the international life science community in academia and industry. These solutions allow life scientists to turn the exponentially growing amount of data into knowledge. Here, we provide an overview of SIB's resources and competence areas, with a strong focus on curated databases and SIB's most popular and widely used resources. In particular, SIB's Bioinformatics resource portal ExPASy features over 150 resources, including UniProtKB/Swiss-Prot, ENZYME, PROSITE, neXtProt, STRING, UniCarbKB, SugarBindDB, SwissRegulon, EPD, arrayMap, Bgee, SWISS-MODEL Repository, OMA, OrthoDB and other databases, which are briefly described in this article

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure &lt; 100 mmHg (n = 1127), estimated glomerular filtration rate &lt; 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

Architecture basée sur HSM pour sécuriser les données sur un serveur d’applications mobiles

RÉSUMÉ : Dans un monde où le besoin de connectivité ne cesse de croître, les applications mobiles deviennent de plus en plus répandues pour automatiser les tâches du quotidien. À présent, acheter un meuble, réserver un billet d’avion et transférer de l’argent à un proche sont devenus des opérations faisables en tout temps et en tout lieu. Cependant, cette mobilité accrue nécessite un transfert important de données et leur stockage sur un serveur donné. Une inquiétude émerge alors sur la sécurité de ces informations. L’histoire nous prouve que ces inquiétudes sont bien fondées, avec les nombreuses expériences de vol de données, d’usurpation d’identité et de destruction d’informations critiques. La littérature propose certes des solutions de sécurité, mais dont les failles les rendent peu fiables. Cette recherche propose une architecture de sécurité basée sur la technologie « Hardware Security Module » (HSM) pour protéger les données abritées sur les serveurs.----------ABSTRACT :In a world where connectivity constantly increases, mobile applications are becoming more and more popular. They allow users to automate tasks that used to require time and effort, like buying a flight ticket, a piece of furniture or transferring funds to a relative. However, these mobile applications deal with numerous bits of information that need to be transferred and stored on a given server. Hence, uncertainties rely on the security of these data. Based on experiences from the literature, our data is not always safe. Identities have been impersonated and vital information stolen or destroyed. While the current practices try to ensure data security, they are flawed and thus unreliable. Hence, this research suggests a security architecture based on the Hardware Security Module (HSM) technology to protect server-side data. This technology is specialized in cryptographic operations and allows us to review some limitations in the current methods

Drinking Status Between Ages 50 and 55 for Men From the San Diego Prospective Study Who Developed DSM-IV Alcohol Abuse or Dependence in Prior Follow-Ups.

ObjectiveAlthough alcohol use disorders (AUDs) are prevalent among older individuals, few studies have examined the course and predictors of AUDs from their onset into the person's 50s. This study describes the AUD course from ages 50 to 55 in participants who developed AUDs according to criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), during the San Diego Prospective Study (SDPS).MethodAmong the 397 university students in the SDPS who were followed about every 5 years from age 20 (before AUD onset), 165 developed AUDs, 156 of whom were interviewed at age 55. Age 50-55 outcomes were compared regarding age 20-50 characteristics. Variables that differed significantly across outcome groups were evaluated using binary logistic regression analyses predicting each outcome type.ResultsBetween ages 50 and 55, 16% had low-risk drinking, 36% had high-risk drinking, 38% met DSM-5 AUD criteria, and 10% were abstinent. Baseline predictors of outcome at ages 50-55 included earlier low levels of response to alcohol predicting DSM-5 AUDs and abstinence, higher drinking frequency predicting DSM-5 diagnoses and lower predicting low-risk drinking, higher participation in treatment and/or self-help groups predicting abstinence and lower predicting DSM-5 AUDs, later ages of AUD onset predicting high-risk drinking, and cannabis use disorders predicting abstinent outcomes.ConclusionsDespite the high functioning of these men, few were abstinent or maintained low-risk drinking during the recent 5 years, and 38% met DSM-5 AUD criteria. The data may be helpful to both clinicians and researchers predicting the future course of AUDs in their older patients and research participants